Jiangsu Changyou Environmental Protection Technology
301557
Hefei conver Holding
603409
LIERDA
832149
SHENGNAN TECHNOLOGY
837006
CHK
831167
CN Stock MarketDetailed Quotes
002864 Shaanxi Panlong Pharmaceutical
- 26.90
- +0.19+0.71%
Market Closed Mar 4 15:00 CST
2.86BMarket Cap24.66P/E (TTM)
26.91High26.52Low17.65KlotVolume26.66Open26.71Pre Close47.23MTurnover2.39%Turnover Ratio25.89P/E (Static)106.28MShares34.6152wk High1.78P/B1.99BFloat Cap22.2552wk Low29.38Limit Up73.98MShs Float80.21Historical High24.04Limit Down1.46%Amplitude10.89Historical Low0.22Dividend TTM26.76Avg Price8.74KlotAsk0.82%Div YieldTTM100Lot Size8.42KlotBid
Shaanxi Panlong Pharmaceutical News
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Announcement on the implementation of equity distribution for the first three quarters of 2024
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Legal Opinion of Beijing Ruiqiang Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Panlong Pharmaceutical: Announcement on Resolutions of the First Extraordinary General Meeting of Shareholders in 2025
Panlong Pharmaceutical: An indicative announcement on the holding of the first extraordinary shareholders\' meeting in 2025
Panlong Pharmaceutical: Announcement on the company\'s acquisition of a food production license
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Panlong Pharmaceutical: Verification opinion of Zhongtai Securities Co., Ltd. on Shaanxi Panlong Pharmaceutical Group Co., Ltd. terminating some convertible bond fund-raising investment projects and permanently supplementing the remaining funds raised with working capital
Panlong Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Fourth Board of Supervisors
Panlong Pharmaceutical: Profit Distribution Plan for the First Three Quarters of 2024
Panlong Pharmaceutical: Announcement of Resolutions of the 22nd Meeting of the Fourth Board of Directors
Panlong Pharmaceutical: Announcement on terminating some convertible bond fund-raising investment projects and permanently supplementing working capital with the remaining funds raised
Panlong Pharmaceutical: Announcement on foreign investment to establish joint ventures and complete industrial and commercial registration
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Report for the third quarter of 2024
Panlong Pharmaceutical: Announcement of Board Resolutions
Panlong Pharmaceutical: Announcement on foreign investment and establishment of joint ventures